Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a new version of the page.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, indicating a versioned update of the site UI rather than a change to the trial information.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded Hepatocellular carcinoma to the page content and included a new resource link to the Genetic and Rare Diseases Information Center. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check83 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision tag updated to v3.4.2 and an older notice (v3.4.1) was removed. These changes pertain to site maintenance and do not alter study details or eligibility information presented on the page.SummaryDifference0.3%

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.